Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
240 studies found for:    "cyclic neutropenia" OR "Neutropenia"
Show Display Options
Rank Status Study
1 Recruiting Russian Clinical Trial of Mesenchymal Cells in Patients With Septic Shock and Severe Neutropenia
Conditions: Septic Shock;   Nonchemotherapy Drug-induced Neutropenia;   Neutropenia After Chemotherapy in Oncohematological Patients;   Neutropenia in Patients With Aplastic Anemia
Interventions: Genetic: Mesenchymal stromal cells;   Drug: Standard therapy of septic shock
2 Recruiting Garlic in Patients With Febrile Neutropenia
Conditions: Chemotherapy;   Neutropenia
Interventions: Dietary Supplement: Solgar Israel;   Other: Placebo capsules
3 Completed Assessment of New Blood Culture Methods on the Microbiological Documentation of Febrile Neutropenia
Conditions: Febrile;   Neutropenia;   Post-chemotherapy
Intervention: Other: sample blood
4 Not yet recruiting Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO
Conditions: Febrile Neutropenia;   Hematological Malignancy
Intervention: Drug: Discontinuation of imipenem-cilastatin or meropenem
5 Active, not recruiting Fatigue and Symptom Burden in Febrile Neutropenia
Conditions: Solid Tumors;   Febrile Neutropenia
Intervention: Behavioral: Questionnaire
6 Completed
Has Results
A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection
Conditions: Mycoses;   Candidiasis;   Aspergillosis;   Cryptococcosis;   Blastomycosis;   Histoplasmosis;   Neutropenia
Interventions: Drug: ITCZ Oral Solution;   Drug: ITCZ-IV
7 Unknown  Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia
Conditions: Brain and Central Nervous System Tumors;   Lymphoma;   Neutropenia;   Psychosocial Effects of Cancer and Its Treatment;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: amoxicillin-clavulanate potassium;   Drug: ciprofloxacin;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment
8 Completed Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor
Conditions: Febrile Neutropenia;   Cancer;   Breast Cancer;   Ovarian Cancer;   Lung Cancer;   Prostate Cancer;   Multiple Myeloma;   Bladder Cancer;   B-cell Lymphoma
Intervention:
9 Recruiting Study of Danggui Buxue Decoction in Preventing Neutropenia
Conditions: Grade 3/4 Neutropenia;   Febrile Neutropenia
Interventions: Drug: DBD;   Drug: Epirubicin;   Drug: Cyclophosphamide;   Drug: Docetaxel
10 Withdrawn Short-term Antibiotic Treatment for Unexplained Fever in Solid Cancer Patients With Febrile Neutropenia
Condition: Febrile Neutropenia
Interventions: Other: Early antibiotic discontinuation;   Other: Usual practice
11 Recruiting Study to Reduce Duration of Antibiotic Therapy in Haematological Patients With Fever and Neutropenia
Condition: Febrile Neutropenia
Interventions: Other: Empirical antimicrobial treatment discontinuation;   Other: Standard empirical antimicrobial treatment discontinuation
12 Completed
Has Results
Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options
Condition: Febrile Neutropenia
Intervention: Drug: Antibacterial agent for the treatment of febrile neutropenia
13 Completed Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia
Conditions: MBL-Deficient;   Neutropenia
Interventions: Drug: Mannan Binding Lectin (MBL);   Drug: Mannan Binding Lectin
14 Not yet recruiting SPOG 2015 FN Definition. A Multi-center Non-inferiority Trial on Safety and Efficacy of a High Versus Low Temperature Limit Defining Fever in Pediatric Patients With Cancer at Risk for Fever in Chemotherapy-induced Neutropenia
Conditions: Cancer;   Pediatrics;   Fever;   Neutropenia;   Fever in Neutropenia
Interventions: Other: 39.0°C temperature limit defining fever;   Other: 38.5°C temperature limit defining fever
15 Completed
Has Results
Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia
Condition: Febrile Neutropenia
Intervention:
16 Completed Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation
Conditions: Allogenic Blood Stem Cell Transplantation;   Febrile Neutropenia
Interventions: Drug: Meropenem;   Drug: Vancomycin;   Drug: Teicoplanin
17 Unknown  A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy
Conditions: NSCLC;   Neutropenia;   Febrile Neutropenia
Interventions: Drug: Pegylated rhG-CSF: 100µg/kg;   Drug: Pegylated rhG-CSF: 6mg;   Drug: placebo and rhG-CSF 5ug/kg/d
18 Completed Anidulafungin in Treating Immunocompromised Children With Neutropenia
Conditions: Infection;   Neutropenia;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Drug: anidulafungin
19 Completed G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy
Conditions: Chemotherapeutic Agent Toxicity;   Neutropenia;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Biological: filgrastim
20 Completed Comparison of the Pharmacodynamics of Imipenem in Patients With Febrile Neutropenia
Condition: Patients With Febrile Neutropenia
Intervention: Drug: Imipenem

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years